EBV (LMP1)
Use
This immunohistochemistry (IHC) assay detects latent membrane protein 1 (LMP1) of Epstein–Barr virus (EBV). It reacts strongly with EBV‑positive lymphoblastoid cell lines and EBV‑infected B‑cell immunoblasts in infectious mononucleosis, and also identifies EBV‑associated neoplasms, particularly EBV‑associated Hodgkin lymphoma.
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
EBV (LMP1)
Protein
Result Turnaround Time
24 hours
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
FFPE tissue block is preferred, or one unbaked, unstained H&E slide (required) plus two to three positively charged unstained slides cut at 4–5 microns. Identifiers must match specimen ID and labeling on requisition.
Storage Instructions
Use cold pack for transport, ensuring it does not directly contact specimen. NYS clients: provide date and time of collection.